Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer

Sci Rep. 2019 Nov 8;9(1):16735. doi: 10.1038/s41598-019-53130-4.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum